Amarin to Present at the Jefferies 2014 Global Healthcare Conference
May 29 2014 - 8:00AM
Marketwired
Amarin to Present at the Jefferies 2014 Global Healthcare
Conference
BEDMINSTER, NJ and DUBLIN,
IRELAND--(Marketwired - May 29, 2014) - Amarin
Corporation plc (NASDAQ: AMRN), a
biopharmaceutical company focused on the commercialization and
development of therapeutics to improve cardiovascular health,
announced today that John F. Thero, Amarin's President and Chief
Executive Officer, is scheduled to present a general company update
at the Jefferies 2014 Global Healthcare Conference on Thursday,
June 5, 2014, at 8:00 a.m. ET.
A live audio webcast of the presentation will be available
at:
http://wsw.com/webcast/jeff82/amrn/
About Amarin
Amarin Corporation plc is a biopharmaceutical company focused on
the commercialization and development of therapeutics to improve
cardiovascular health. Amarin's product development program
leverages its extensive experience in lipid science and the
potential therapeutic benefits of polyunsaturated fatty
acids. Vascepa® (icosapent
ethyl), Amarin's first FDA approved product, is
a patented, ultra pure omega-3 fatty acid product comprising not
less than 96% EPA and is available by prescription. For
more information about Vascepa visit www.vascepa.com. For more
information about Amarin visit www.amarincorp.com.
Amarin contact information: Michael FarrellInvestor Relations
and Corporate CommunicationsAmarin CorporationIn U.S.: +1 (908)
719-1315investor.relations@amarincorp.com
Amarin (NASDAQ:AMRN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Amarin (NASDAQ:AMRN)
Historical Stock Chart
From Sep 2023 to Sep 2024